Sentences with phrase «cancer research program of»

Not exact matches

The co-ordinator of the federal cancer program refers to it as «the most challenging but the most frustrating area of research today.»

They are proudly celebrating their 20th anniversary of raising awareness and funds for cancer research, prevention programs and support services.

In a letter to OEHHA opposing the listing of 4 - MEI, Dr. Ernest E. McConnell, former Director of the National Toxicology Program's Toxicology Research and Testing Program, wrote: «NTP has not included 4 - MEI on its list of chemicals causing cancer; i.e., the Report on Carcinogens.»

As part of the fight to help eradicate breast cancer, Devotion Spirits, Inc., will donate proceeds from every bottle of Devotion Vodka's Perfect Cosmo sold (both on - premise and off - premise) throughout the month of October to the Pink & Bloom Foundation, a 501c3 organization committed to raising funds for cancer research and advocacy programs.

At Nationwide Children's, we help kids everywhere and provide life - saving research and care in Cancer, NICU, The Heart Center, Muscular Dystrophy and all of our nationally ranked clinical programs.

«Our findings suggest that teens and young adults who seek indoor tanning may be especially vulnerable to developing BCC, the most common form of skin cancer, at a young age,» said lead author Professor Margaret Karagas, co-director of the Cancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at Dartcancer, at a young age,» said lead author Professor Margaret Karagas, co-director of the Cancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at DartCancer Epidemiology and Chemopreventon Research Program at the Norris Cotton Cancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at DartCancer Center and Director of the Children's Environmental Health and Disease Prevention Research Center at Dartmouth.

The goal of this program is to train leaders in cancer prevention and control; it provides a great opportunity to synthesize my interests in research and policy.

«Because resource availability varies widely, both among and within countries, we need to adjust strategies to improve access to HPV vaccination everywhere,» said Silvia de Sanjosé, MD, PhD, co-chair of the Expert Panel that developed the guideline and head of the Cancer Epidemiology Research Program at Institut Català d'Oncologia in Barcelona, Spain.

By building on the skills they brought to the program and acquiring new ones during M.P.H. training and mentored research, fellows have the opportunity and the freedom to develop and pursue their own original ideas in the field of cancer prevention and control.

With funding from the Alberta Cancer Board, the National Science and Engineering Research Council, the Canadian Institutes of Health Research (CIHR), the Canadian Foundation for Innovation, and the Alberta Innovation and Science Research Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coResearch Council, the Canadian Institutes of Health Research (CIHR), the Canadian Foundation for Innovation, and the Alberta Innovation and Science Research Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coResearch (CIHR), the Canadian Foundation for Innovation, and the Alberta Innovation and Science Research Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coResearch Investment Program, the University of Alberta (UA) in Edmonton has become a major center of nanotechnology research and has fostered the spin - off and growth of a host of coresearch and has fostered the spin - off and growth of a host of companies.

He holds the Canada Research Chair in Stem Cell Biology and is Director of the Cancer Stem Cell Program at the Ontario Institute for Cancer Research.

While pursuing her project on how environmental contaminants and oxidative stress cause lung cancer, Gelhaus complemented her postdoctoral training by spending some time with other PIs at Penn. «She has worked hard to develop skills that are independent of those available in my own laboratory while working on a project that is central to my research program,» Blair writes in an e-mail to Science Careers.

Steven Narod, director of the Familial Breast Cancer Research Unit at Women's College Research Institution in Toronto, believes that cost and not flawed computer programs are to blame for undertesting.

Today, an article published in Cancer Discovery by Manel Esteller, Director of the Epigenetics and Cancer Biology Program of Bellvitge Biomedical Research Institute (IDIBELL), ICREA Researcher and Professor of Genetics at the University of Barcelona, explains that this RNA also has its own spelling and grammar, just like DNA.

«We are looking to optimize the combinations of targeted therapies and the scheduling of those therapies so we can improve tumor shrinkage and minimize potential toxicities for a patient,» said Andrew Aplin, PhD, Associate Director for Basic Research and the Program Leader for Cancer Cell Biology and Signaling (CCBS) in the NCI - designated Sidney Kimmel Cancer Center at Jefferson Health.

Extending national breast cancer screening programs to women over the age of 70 does not result in a decrease in the numbers of cancers detected at advanced stages, according to new research from The Netherlands.

Dr Gerrit - Jan Liefers (MD, PhD), a surgical oncologist and head of the geriatric oncology research group at Leiden University Medical Centre (Leiden, The Netherlands), said: «For a screening program to be effective, one would expect that the incidence of early stage breast cancer would increase while the incidence of advanced stage cancer would decrease because any cancer would have been detected at an earlier stage.

University of Calgary researchers including Luchman, Weiss and Dr. Greg Cairncross — director of SACRI, and leader of the Terry Fox Research Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobResearch Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobresearch program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblprogram at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblacancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblaCancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblProgram), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblastoma.

Principal investigator Leena Gandhi, MD, PhD, director of the thoracic medical oncology program at Perlmutter Cancer Center at NYU Langone Health and associate professor of Medicine in the division of Medical Oncology at NYU School of Medicine, presented these findings April 16 at the American Association for Cancer Research (AACR) Annual Meeting 2018 in Chicago.

The H Foundation and a Signal Transduction in Cancer Training Program of the National Cancer Institute supported the research.

In his day job, at the University of Texas MD Anderson Cancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the immunotherapy division of the Moon Shots Program, a multidisciplinary effort tackling cancer mortCancer Center in Houston, Allison serves as chair of the immunology department, deputy director of the David H. Koch Center for Applied Research of Genitourinary Cancers and executive director of the immunotherapy division of the Moon Shots Program, a multidisciplinary effort tackling cancer mortcancer mortality.

«The findings of both studies support a growing body of research that suggests lifestyle interventions lower biomarkers associated with breast cancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both research that suggests lifestyle interventions lower biomarkers associated with breast cancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stcancer recurrence and mortality, and improve quality of life,» said Melinda Irwin, PhD, co-program leader of the Cancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Prevention and Control Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both Research Program at Yale Cancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both stCancer Center, associate professor of Epidemiology at Yale School of Public Health, and principal investigator on both studies.

«This is the first time that this specific protein - protein signaling complex has been identified in GBM, and it gives us a new potential target for drug development,» says Fisher, Thelma Newmeyer Corman Endowed Chair in Cancer Research and co-leader of the Cancer Molecular Genetics research program at VCU Massey, professor and chair of the Department of Human and Molecular Genetics at the VCU School of Medicine, and director of tResearch and co-leader of the Cancer Molecular Genetics research program at VCU Massey, professor and chair of the Department of Human and Molecular Genetics at the VCU School of Medicine, and director of tresearch program at VCU Massey, professor and chair of the Department of Human and Molecular Genetics at the VCU School of Medicine, and director of the VIMM.

«A deeper analysis of the primary tumor may be all we need to prevent metastases,» said UNC Lineberger's Lisa A. Carey, MD, physician - in - chief of the N.C. Cancer Hospital and the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, who leads the Tumor Donation Program.

Based at the Cancer Research Institute in New York, Old is the director of the Cancer Vaccine Collaborative, an international program dedicated to fighting cancer from the insidCancer Research Institute in New York, Old is the director of the Cancer Vaccine Collaborative, an international program dedicated to fighting cancer from the insidCancer Vaccine Collaborative, an international program dedicated to fighting cancer from the insidcancer from the inside out.

Jean - Pierre Issa, MD, Director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine and co-Leader of the Cancer Epigenetics Program at the Fox Chase Cancer Center is lead author of the study, which has been published August 19 in the journal, Lancet Oncology.

New research shows that microRNA - 486 is a potent tumor - suppressor molecule in lung cancer, and that the it helps regulate the proliferation and migration of lung - cancer cells, and the induction of programmed cell death, or apoptosis, in those cells.

NIH supports both innovation and «optimization that can benefit patients — such as making a cancer drug less toxic or more potent,» says Andilibi, now program director of the US National Cancer Institute's Small Business Innovation Research (SBIR) Development Center in Bethesda, Marcancer drug less toxic or more potent,» says Andilibi, now program director of the US National Cancer Institute's Small Business Innovation Research (SBIR) Development Center in Bethesda, MarCancer Institute's Small Business Innovation Research (SBIR) Development Center in Bethesda, Maryland.

In these vesicles, we saw the EGFR and HER2 receptors being broken down, but we also saw our negative control receptor, c - MET,» said Dent, who is the Universal Corporation Chair in Cancer Cell Signaling and a member of the Cancer Cell Signaling research program at Massey.

Reed is a member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and an associate professor in the Department of Physics at the VCU College of Humanities and Sciences.

«Pancreatic cancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Lacancer cells are deadly because they program nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU Lprogram nearby immune cells to permit the tumors to survive and grow,» says study author George Miller, MD, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU LaCancer Immunology Program at Perlmutter and vice chair for research in the Department of Surgery at NYU LProgram at Perlmutter and vice chair for research in the Department of Surgery at NYU Langone.

This study was supported by Norma C. and Albert I. Geller via the Gynecological Cancer Translation Research Program at the Case Comprehensive Cancer Center, and grants from The Mary Kay Foundation (to A.D. and R.X.), the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under the NIH Director's New Innovator award number DP2HD084068 (to R.X.), The National Cancer Institute award number R011CA197780 - 01A1 (to A.D.), and The Young Scientist Foundation (A.D.Of Child Health & Human Development of the National Institutes of Health under the NIH Director's New Innovator award number DP2HD084068 (to R.X.), The National Cancer Institute award number R011CA197780 - 01A1 (to A.D.), and The Young Scientist Foundation (A.D.of the National Institutes of Health under the NIH Director's New Innovator award number DP2HD084068 (to R.X.), The National Cancer Institute award number R011CA197780 - 01A1 (to A.D.), and The Young Scientist Foundation (A.D.of Health under the NIH Director's New Innovator award number DP2HD084068 (to R.X.), The National Cancer Institute award number R011CA197780 - 01A1 (to A.D.), and The Young Scientist Foundation (A.D.).

The tech transfer internship program at the University of Michigan is run by Elaine Brock, the director of the Medical School's Office of Technology Transfer and Corporate Research, a lawyer who was also trained in health services administration; and assistant director Maria Sippola - Thiele, a former National Cancer Institute postdoc who subsequently got her M.B.A. from the University of Michigan.

«We still have a long way to go and many challenges to overcome before we will have therapies that are ready for clinical use, but this is a significant first step in the process,» says Emdad, member of the Cancer Molecular Genetics research program at Massey, assistant professor in the VCU Department of Human and Molecular Genetics and member of the VIMM.

«As someone who researches pancreatic cancer, I think this discovery is significant because it defines mechanisms that lead to this cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Instcancer, I think this discovery is significant because it defines mechanisms that lead to this cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Instcancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer InstCancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer InstCancer Institute.

«We challenged a current dogma in the field that emphasized PLK1's role in mitosis (cell division) as a primary mechanism for cancer growth,» says Zheng Fu, Ph.D., lead investigator on the study, member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of Medcancer growth,» says Zheng Fu, Ph.D., lead investigator on the study, member of the Cancer Molecular Genetics research program at VCU Massey Cancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of MedCancer Molecular Genetics research program at VCU Massey Cancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of MedCancer Center and assistant professor in the Department of Human and Molecular Genetics at the VCU School of Medicine.

Funders of the work include the Department of Defense Breast Cancer Research Program, the National Institutes of Health, the Sidney Kimmel Foundation, and the UCSF Program in Breakthrough Biomedical Research.

A different pathway is used to train students in the combined degree program at the University of Texas Health Science Center at Houston (UT Houston) and the University of Texas M. D. Anderson Cancer Center, where the goal is to produce physician - scientists who will pursue careers in clinical research.

The session featured Sadis Matalon, associate dean of the Office of Postdoctoral Education at the University of Alabama, Birmingham (UAB); Jonathan Wiest, associate director for Training and Education at the National Cancer Institute's (NCI?s) Center for Cancer Research (CCR); and Mary Anne With, director of Institutional Oversight for the Postdoctoral Program at Los Alamos National Laboratory (LANL).

Joining forces with dermatologists and oncologists from the University Hospital in Zurich and backed by the University Research Priority Program «Translational Cancer Research,» Sommer's team was able to demonstrate that, in melanoma cells, the epigenetic factor EZH2 controls genes that govern tumor growth as well as genes that are important for the formation of metastases.

«Because of relatively low survival rates and their advancing age, these patients tend to be poor candidates for aggressive therapies, like a bone marrow transplant,» said senior author Catriona Jamieson, MD, PhD, professor of medicine, chief of the Division of Regenerative Medicine at UC San Diego School of Medicine and director of the Stem Cell Research Program at Moores Cancer Center.

«Most of the scientific community in Spain is looking with sadness to the current events,» Manel Esteller, director of the Cancer Epigenetics and Biology Program at the Bellvitge Biomedical Research Institute in Barcelona, writes in an e-mail to ScienceInsider.

In the early 1990s, the group lobbied to create a Department of Defense breast cancer research program now funded at $ 150 million a year.

The research was supported by the National Cancer Institute, Specialized Programs of Research Excellence (SPORE) grant, National Institutes of Health, the Dermatology Foundation, the Children's Tumor Foundation, and the Burroughs Wellcoresearch was supported by the National Cancer Institute, Specialized Programs of Research Excellence (SPORE) grant, National Institutes of Health, the Dermatology Foundation, the Children's Tumor Foundation, and the Burroughs WellcoResearch Excellence (SPORE) grant, National Institutes of Health, the Dermatology Foundation, the Children's Tumor Foundation, and the Burroughs Wellcome Fund.

What's really impressive about Babar's accomplishment is that he did the work for both papers — one on the role of a population of stem cells in lung cancer development (published in Cell) the other on gene expression in group A Streptococcus (published in PNAS)-- as a participant in summer undergraduate research programs.

Today, an article published in Cell by Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA researcher and Professor of Genetics at the University of Barcelona, describes the possible existence of a sixth DNA base, the methyl - adenine (mA), which also help determine the epigenome and would therefore be key in the life of the cells.

Today, an article published in the prestigious journal Molecular Cell by Manel Esteller, Director of Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA researcher and Professor of Genetics at the University of Barcelona, provides a twist over this mystery.

Other UT Southwestern researchers involved in the study were Dr. Ramzi Abdulrahman, Associate Professor of Radiation Oncology; Dr. Arthur Sagalowsky, Professor of Urology and Surgery, co-leader of the Kidney Cancer Program, who holds The Dr. Paul Peters Chair in Urology in Memory of Rumsey and Louis Strickland; Dr. Ivan Pedrosa, Associate Professor of Radiology and the Advanced Imaging Research Center, co-leader of the Kidney Cancer Program, who holds the Jack Reynolds, M.D., Chair in Radiology; Dr. Hak Choy, Chair and Professor of Radiation Oncology who holds The Nancy B. & Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research; and Dr. James Brugarolas, Associate Professor of Internal Medicine and Developmental Biology, leader of the Kidney Cancer Program, and Virginia Murchison Linthicum Endowed Scholar; and other researchers including Stephen Chun, Dr. Nathan Cannon, and Dr. Nathan Kim.

The research team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inresearch team includes investigators from Mayo Clinic in Florida and Mayo Clinic SPORE in Pancreatic Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InstCancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Instcancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer InResearch Excellence (SPORE) grant for pancreatic cancer from the National Cancer Instcancer from the National Cancer InstCancer Institute.

«Our research shows that the protein GSK3 plays a crucial role in helping B cells meet the energy needs of their distinct states,» says Robert Rickert, Ph.D., director of the Tumor Microenvironment and Cancer Immunology Program at Sanford Burnham Prebys Medical Discovery Institute (SBP).